Related by context. All words. (Click for frequent words.) 73 investigational oral hepatitis C 73 intrahepatic bile duct 73 non nucleoside inhibitor 72 Enzastaurin 72 papillary renal cell carcinoma 72 Mg Usa 72 MAGE A3 ASCI 71 receptor tyrosine kinase inhibitor 71 relapsed MM 71 metastatic malignant 71 virus HCV protease inhibitor 71 MGd 71 essential thrombocythemia ET 71 PF # [002] 71 accumulate preferentially 70 AKT inhibitor 70 sorafenib Nexavar 70 mertansine 70 Bayer HealthCare Onyx Pharmaceuticals 70 Rigel R# 70 Silodosin 70 Aflibercept 70 thalidomide Thalomid 70 Phase 1b clinical trials 70 GW# [003] 70 adecatumumab MT# 70 novel VDA molecule 70 Nexavar sorafenib 70 Torisel temsirolimus 70 Sapacitabine 70 PI3K/Akt pathway inhibitor 70 kidney urologic 69 novel histone deacetylase 69 Initiates Enrollment 69 Dacogen decitabine 69 midstage clinical 69 dasatinib Sprycel ® 69 histone deacetylase inhibitor 69 polycythemia vera PV 69 Peginterferon alfa 2b 69 Immunotherapeutic 69 gastrointestinal stromal 69 Kinase Inhibitor 69 Omacetaxine 69 reversible inhibitor 69 Kinesin Spindle Protein KSP 69 Xeloda ® 69 MKC# MT 69 Angiotensin Converting Enzyme 69 IgG1 monoclonal antibody 69 Peptide YY 69 Phase #b/#a clinical 69 CYT# potent vascular disrupting 69 sorafenib tablets 69 metastatic colorectal 69 Panzem NCD 69 oral Janus kinase 69 2 methoxyestradiol 69 Initiate Phase 69 Telik logo TELINTRA 69 KSP inhibitor 69 Orally administered 69 monoclonal antibody conjugated 69 Mg Uk 68 orally administered inhibitor 68 multi kinase inhibitor 68 Janus kinase 68 treatment naive genotype 68 GVAX ® 68 cortisol synthesis 68 ThermoDox ® clinical 68 Achieves Primary Endpoint 68 LymphoStat B TM 68 LymphoStat B belimumab 68 Prolongs Survival 68 bladder ovarian 68 Protease Inhibitor 68 number NCT# ClinicalTrials.gov 68 histone deacetylase HDAC inhibitor 68 AAG geldanamycin analog 68 Ribavirin causes 68 PNP inhibitor 68 INSPIRE Trial Phase III 68 Interferon beta 1b 68 Combination REOLYSIN R 68 Investigational Oral 68 reduce serum phosphate 68 gastrin analogue TT 68 resistant hormone refractory 68 Initiates Phase II 68 Tarceva TM 68 liposomal formulation 68 Tesmilifene 68 selective phosphodiesterase 68 including eniluracil ADH 68 Hsp# Inhibitor 68 recurrent metastatic 68 plasma kallikrein inhibitor 68 non resectable metastatic 68 Completes Patient Enrollment 68 novel tubulin binding 68 anti PlGF 68 lexidronam injection 68 hyaluronidase enzyme 68 Xanafide 68 Cloretazine 68 PSMA ADC 68 LungAlert TM 68 multicenter Phase II 68 Initiates Clinical Trial 68 Sudhir Agrawal D.Phil 68 vapreotide acetate 68 huC# DM4 68 galiximab 68 RTP #i 68 vinorelbine tartrate 68 ALN HPN 68 PrevOnco 68 estrogen receptor antagonist 68 pan histone deacetylase 68 microtubule inhibitor 68 adalimumab Humira 68 alkylating agent 68 evaluating tivozanib 68 nucleotide analogue 68 refractory chronic lymphocytic 68 Tykerb lapatinib 68 HCV NS5B polymerase 68 sunitinib Sutent 68 ara C 68 FUSILEV enhances 68 cisplatin gemcitabine 68 CYP#A# CYP#D# 68 dasatinib Sprycel 68 humanized therapeutic 68 nucleotide analog 68 ADP receptor antagonist 68 Pharmacokinetics PK 68 targeted antifolate 67 ALN VSP Phase 67 Bucindolol 67 Sprycel dasatinib 67 Temsirolimus 67 EOquin TM phase 67 Onconase 67 Eltrombopag 67 vesicular monoamine transporter 67 FOLOTYN ® 67 GSK '# 67 erlotinib Tarceva ® 67 protein tyrosine phosphatase 1B 67 Camptosar ® 67 chronic idiopathic thrombocytopenic purpura 67 ispinesib SB # 67 Liprotamase 67 Naive Patients 67 acyclovir Lauriad R 67 gefitinib Iressa 67 CTAP# Capsules 67 pralatrexate injection folate analogue 67 DNA intercalator 67 carcinoma HCC 67 Darinaparsin 67 immunomodulatory properties 67 Muraglitazar 67 HDAC Inhibitor 67 Zarnestra 67 ZACTIMA 67 MetroGel 67 LHRH receptor positive 67 phase III isavuconazole 67 aurora kinase inhibitor 67 PLX STROKE targeting 67 OncoVex 67 novel defensin mimetic 67 candidate deforolimus 67 selective modulator 67 VNP#M 67 etanercept Enbrel 67 Trandolapril 67 albiglutide 67 Safinamide 67 Trastuzumab DM1 67 Degarelix 67 RhuDex R 67 chimeric monoclonal antibody 67 Epidermal Growth Factor Receptor 67 azilsartan medoxomil 67 targeted radiotherapeutic 67 oropharyngeal candidiasis OPC 67 sunitinib Sutent ® 67 novel emulsion formulation 67 IMiDs ® 67 sodium thiosulfate STS 67 5 HT2A inverse 67 sodium glucose cotransporter 67 initiated Phase Ib 67 Prednisone Against Refractory 67 gamma secretase inhibitor 67 IAP inhibitor 67 Velcade bortezomib 67 Azacitidine 67 Hycamtin ® 67 potent triglyceride lowering 67 Receives Orphan Drug Designation 67 NS5b 67 polycythemia vera essential thrombocythemia 67 radiation sensitizer 67 ThermoDox R 67 pioglitazone hydrochloride 67 BRIM2 66 5 HT4 66 Vidaza azacitidine 66 Phase 2b Clinical Trial 66 substantially excreted 66 Teriflunomide 66 Pemetrexed 66 sarcoma melanoma 66 proteasome inhibitor 66 Pathway Inhibitor 66 cutaneous T 66 Successfully Completes Phase 66 myelodysplastic myeloproliferative diseases 66 Monoclonal antibody 66 humanised monoclonal antibody 66 Parathyroid Hormone 66 tumor xenograft models 66 Crofelemer budesonide foam 66 small molecule Hedgehog 66 Dose Ranging Study 66 R lenalidomide 66 candesartan cilexetil 66 dexamethasone Decadron 66 TNFerade TM 66 VEGFR2 inhibitor 66 Talabostat 66 cyclin dependent kinase inhibitor 66 phase IIb study 66 anastrazole 66 Phase Ib clinical 66 Xelox 66 lenalidomide Revlimid 66 deCODE AF TM 66 HepDirect prodrug 66 brivaracetam 66 IL# PE#QQR 66 RhuDex TM 66 methylnaltrexone bromide 66 Daclizumab 66 cisplatin resistant 66 Submits Response 66 TNFerade ™ 66 DEB# 66 oral anti arrhythmic 66 octreotide acetate 66 Panzem R 66 oral nucleoside analogue 66 Romidepsin 66 Afinitor everolimus 66 huN# DM1 66 immune globulin intravenous 66 Hedgehog Pathway Inhibitor 66 reslizumab 66 verteporfin 66 alpha folate receptor 66 androgen receptor antagonist 66 lenalidomide Revlimid R 66 non resectable 66 pan HDAC inhibitor 66 Ixempra 66 tumors GIST 66 Oral Fingolimod 66 Treanda bendamustine 66 Nexavar tablets 66 ongoing Phase 1b 66 docetaxel Taxotere R 66 Presents Positive 66 PANVAC VF 66 aurora kinase 66 SinuNase ™ 66 Phase Ib II 66 hypereosinophilic syndrome 66 Randomized Phase II 66 acetonide FA 66 triciribine phosphate monohydrate 66 beta 1a 66 Darapladib 66 humanized interleukin 6 66 cetuximab Erbitux R 66 Pivotal Phase III 66 CLL SLL 66 HCV SPRINT 66 Cloretazine ® 66 peptidic compound 66 Seliciclib 66 tramiprosate Alzhemed TM 66 Vidaza R 66 zoledronic acid Reclast 66 Shows Promise Against 66 recurrent glioblastoma multiforme 66 Phase 2b Study 66 nilotinib Tasigna ® 66 Randomized Phase 66 aripiprazole Abilify 66 trastuzumab DM1 T DM1 66 corticosteroid dexamethasone 66 demonstrated antitumor activity 66 untreated metastatic colorectal 66 progressive metastatic prostate 66 mTOR mammalian target 66 BRIM3 66 ZOLINZA 66 triggers apoptosis programmed 66 ovarian prostate 66 TASKi2 66 PDX pralatrexate 66 highly selective inhibitor 66 mesylate 66 human IgG1 monoclonal 66 TransVax TM 66 HCV Genotype 66 Aurora Kinase 66 2 inhibitor CYT# 66 Edurant 66 investigational protease inhibitor 66 advanced metastatic renal 66 cromolyn sodium 66 Deforolimus 66 Febuxostat 66 Initiates Phase III 66 selectively inhibited 66 Lubiprostone 66 Personalized Immunotherapy 66 Nasdaq ACHN 66 Entecavir 66 Initiates Clinical 66 5 HT2A serotonin 66 selective kinase inhibitor 66 Gemzar gemcitabine 66 HMG CoA reductase inhibitors 66 agonistic human 66 targeted nucleotide prodrug 66 Myelodysplastic Syndrome MDS 66 intravesical instillation 66 rALLy clinical trial 66 Reports Preclinical Data 66 EGFr expressing metastatic colorectal 66 indinavir Crixivan 66 Lymphocytic 66 intravesical infusion therapy 66 BAY #-# 66 ixabepilone 66 YONDELIS 66 IKK epsilon 66 controlled multicenter Phase 66 Vicinium TM 66 #-# Full Text 66 TLK# 66 Tanespimycin 66 BCIRG 66 non porcine pancreatic 66 leukemia AML 66 CYT# vascular disrupting 66 bortezomib Velcade R 66 include ColorectAlert TM 66 PPAR gamma agonist 66 cathepsin K inhibitor 66 Xcellerated T Cells 66 murine model 66 Plaquenil 66 small molecule glucokinase 65 memantine HCl 65 rHuPH# recombinant human 65 OMP #R# 65 malignant ascites 65 Sustiva efavirenz 65 investigational integrase inhibitor 65 insulin glulisine 65 Romiplostim 65 MEK inhibitor ARRY 65 Janus Kinase 65 hyperphenylalaninemia HPA due 65 hormone refractory metastatic prostate 65 HoFH 65 gastrointestinal stromal tumors GISTs 65 ExTRACT TIMI 65 Bazedoxifene 65 Transdrug R 65 docetaxel Taxotere ® 65 alpha 2A adrenergic 65 Aliskiren 65 MKC# MKC# PP 65 nucleoside analog 65 G#DT 65 ToGA 65 IGF 1R inhibitor 65 Evoltra ® 65 mitogen activated ERK kinase 65 sulfonylhydrazine class 65 forodesine 65 directed radiotherapeutic antibody 65 GRNOPC1 contains 65 miconazole Lauriad ® 65 HCV polymerase 65 IMiDs R 65 Alfacell proprietary ribonuclease 65 multikinase inhibitor 65 gemcitabine cisplatin 65 NS5B polymerase 65 eritoran 65 Mycophenolate Mofetil 65 Meets Primary Endpoint 65 HuMax 65 DNA methyltransferase inhibitors 65 mouse xenograft models 65 alvespimycin 65 Cariprazine 65 Monopril 65 Temodar ® 65 solithromycin 65 Cancer Incidence Mortality 65 EGFR HER2 65 Bayer Nexavar 65 ARRY # 65 commercializing oxidized glutathione 65 p# MAP kinase inhibitor 65 Vidaza ® 65 OMP #M# 65 Vitrasert R 65 BMS # 65 Begins Dosing 65 Valproic acid 65 Severe Sepsis 65 evaluating satraplatin 65 e antigen HBeAg 65 Brentuximab Vedotin SGN 65 Zolinza 65 J Am Coll 65 treatment naïve genotype 65 bevirimat Study 65 oral dihydropyrimidine dehydrogenase DPD 65 HGS ETR1 mapatumumab 65 Carotid Revascularization Endarterectomy vs. 65 vaccine GMK 65 antiangiogenic agent 65 Clinical Trials Update 65 secretory phospholipase A2 65 investigational oral inhibitor 65 AEGR 65 Neulasta R 65 intranasal formulation 65 pravastatin Pravachol 65 Vandetanib 65 TRO# 65 Glioblastoma Multiforme 65 acute myeloid 65 MTP inhibitor 65 prokinetic agent 65 proprietary radiolabeled monoclonal 65 FOLFIRI chemotherapy 65 Inotek Pharmaceuticals Corporation 65 J Biol Chem 65 BrachySil TM 65 Dasatinib 65 underwent surgical resection 65 anti secretory 65 sulindac 65 elotuzumab 65 Aplidin 65 Bezielle 65 potent antiproliferative 65 Anidulafungin 65 Atrasentan 65 MCSP respectively 65 deCODE ProstateCancer TM 65 Presents Preclinical 65 Etravirine 65 TO AVOID PREGNANCY WHILE 65 syngeneic 65 myelofibrosis MF 65 compound INCB# 65 Ozarelix 65 anticancer compound 65 Refractory Hodgkin Lymphoma 65 topically administered 65 Phase IIb clinical trials 65 heFH 65 induced macular edema 65 Glucophage XR 65 Gamunex C 65 Denufosol 65 pancreatic prostate 65 BRAF mutant 65 Am J Epidemiol 65 Polymerase Inhibitor 65 Letairis ambrisentan 65 antibody MAb 65 Irinotecan 65 AFREZZA TM 65 small molecule tyrosine 65 systemic anaplastic large 65 ADVANCE PD 65 potently inhibits 65 lung pancreatic 65 Tofacitinib 65 DNA demethylating agent 65 investigational humanized monoclonal antibody 65 Cetuximab Erbitux 65 Solazed 65 PRN FDA Approves 65 Antiangiogenic 65 approved incretin mimetic 65 Transdermal Patch 65 Neuvenge 65 Matrix Phase 2b 65 Proellex TM 65 bevacizumab Avastin R 65 relapsed leukemia 65 CRF1 receptor antagonist 65 therapeutic monoclonal antibody 65 developing Zerenex ferric 65 Cotara ® 65 Adenoviral 65 Hodgkin lymphoma HL 65 JAK2 inhibitor 65 metaglidasen 65 Phase IIa Clinical Trial 65 Non Alcoholic Steatohepatitis 65 myelofibrosis polycythemia vera 65 generation purine nucleoside 65 hydroxamic acid 65 imatinib Gleevec ® 65 hepatocellular carcinoma liver 65 platform HDL Mimetic 65 gemcitabine Gemzar ® 65 Submits IND 65 iobenguane 65 superficial basal cell carcinoma 65 Investigational Compound 65 oral rivaroxaban 65 sunitinib malate 65 Endometrial 65 Phase 2b Trial 65 Allogeneic 65 finasteride Proscar 65 Elvitegravir 65 EOquin TM 65 cyclophosphamide methotrexate 65 topical gel formulation 65 Diabetic Neuropathy 65 Anti Tumor 65 Gleevec imatinib mesylate 65 targeting miR 65 Crit Rev 65 itraconazole Sporanox 65 psoriasis rheumatoid arthritis 65 Tumor Response 65 Ceflatonin R 65 AVASTIN 65 gets USFDA nod 65 acadesine 65 chemosensitizer 65 Lenocta 65 Ecallantide 65 Hydrochlorothiazide Tablets 65 rosiglitazone maleate 65 fosbretabulin 64 AMEX RGN 64 Anticancer Compound 64 Intravitreal 64 Inc. Nasdaq MITI 64 budesonide foam 64 tamoxifen citrate 64 Ganciclovir 64 4SC AG ISIN DE# 64 radiolabeled TM# 64 hypoxia selective 64 CAMMS# 64 regorafenib 64 oral ridaforolimus 64 chronic thromboembolic pulmonary 64 novel therapeutic antibodies 64 HQK 64 hormone LHRH antagonist 64 Folfox 64 UPLYSO 64 Arranon 64 tipifarnib 64 5 fluorouracil leucovorin 64 combines bupropion 64 Pertuzumab 64 Ridaforolimus 64 BZA CE 64 Hormone Refractory Prostate Cancer 64 #mg #mg #mg [003] 64 selective inhibitor 64 MEK Inhibitor 64 AN# topical anti 64 liver resection surgeries 64 ANN INTERN MED 64 phase IIb trial 64 follicular Non Hodgkin 64 Pyridorin TM 64 treat chronic sinusitis 64 renal cell carcinomas 64 topoisomerase II inhibitor 64 assessing T DM1 64 Granted Orphan Drug 64 protein kinase inhibitor 64 Granulocyte Colony Stimulating Factor 64 midstage trials 64 Arch Intern Med 64 CHAMPION PCI 64 Belerofon 64 non nucleoside HCV 64 Therapeutic Competitors Companies 64 PDE4 inhibitor 64 depsipeptide 64 ziprasidone Geodon 64 hematological cancers notably 64 SPL# Gel vaginal microbicide 64 Submits NDA 64 GRNVAC1 64 biologic DMARD 64 unresectable tumors 64 Phase Ib IIa 64 Factor VIIa 64 oral prodrug 64 Metastatic Melanoma 64 pioglitazone HCl 64 Amgen Neulasta R 64 Quinamed R 64 CDK cyclin dependent 64 Methylnaltrexone 64 Losartan 64 Valopicitabine 64 Crizotinib 64 induced mucositis 64 denileukin diftitox 64 Saxagliptin 64 Adenosine A2A 64 Medidur TM FA 64 metastatic androgen independent 64 Neulasta ® 64 Bevacizumab Avastin 64 k Premarket Notification 64 PrevOnco ™ 64 metastatic gastric 64 NS#/#A protease 64 Dabigatran etexilate 64 lead Aganocide compound 64 EXPLORE Xa 64 oral ghrelin agonist 64 Lovastatin 64 BRAF inhibitor 64 R sorafenib tablets 64 PARP inhibitor 64 Grb 2 64 Inflammatory Markers 64 thetreatment 64 Bendamustine 64 FOLFOX6 64 metastatic bladder 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 Indibulin ZIO 64 Fludara ® 64 hepatoma 64 Nexavar ® 64 Viread tenofovir disoproxil fumarate 64 thiazolides 64 Kuvan sapropterin dihydrochloride 64 sevelamer hydrochloride 64 Nitazoxanide 64 Preclinical Models 64 Ann Intern Med 64 Antitumor Activity 64 Lenocta TM 64 adenosine A2A 64 XL# anticancer compounds 64 cytomegalovirus immune globulin 64 cholesteryl ester transfer 64 basal bolus regimen 64 class anticancer quinolone 64 ovarian pancreatic 64 Vascular Disrupting Agent 64 LUX Lung 64 lintuzumab SGN 64 Preclinical Study 64 sargramostim 64 Suppl. 64 BIOV 64 Emtriva Viread 64 multicenter Phase III 64 JAK2 Inhibitor 64 acid phosphatase PAP 64 PKC# 64 delivers fluocinolone acetonide FA 64 Sutent sunitinib malate 64 receptor inhibiting monoclonal 64 AQD class 64 Genasense ® oblimersen 64 Aurora kinase 64 cells overexpressing 64 TELINTRA R 64 BiTE R 64 By JENNIFER LEARN 64 raloxifene Evista 64 anthracycline taxane 64 COLAZAL R 64 K ras mutations 64 Adjuvant Treatment 64 Albuferon TM 64 Genotyping Test 64 Epirubicin 64 oral picoplatin 64 non peptidic protease 64 ergot derivatives 64 cetuximab Erbitux 64 Philadelphia Chromosome Positive 64 ALS #-# 64 Presents Positive Preclinical 64 kinesin spindle protein KSP 64 prednisone prednisolone plus 64 Budesonide foam crofelemer 64 phase Ib 64 Amgen Neulasta ® 64 selective agonist 64 MBRX 64 Vaccine Adjuvant 64 Alimta pemetrexed 64 diarrhea predominant irritable 64 Zorbtive TM 64 oncolytic virus therapies 64 evaluating T DM1 64 Demonstrates Potent 64 immunosuppressant drug 64 Clinical Trial Results 64 Plavix clopidogrel bisulfate 64 Aurora kinase inhibitor 64 methionine aminopeptidase 64 Panzem R NCD 64 TKB# 64 Subgroup analysis 64 Kit CD# positive 64 PEG IFN 64 candidates Azedra TM 64 Risperidone Oral Solution 64 daptomycin 64 Preclinical studies suggest 64 MEK inhibitor 64 Mylan Receives Approval 64 Presents Preclinical Data 64 Commences Phase 64 epoetin alpha 64 potent suppressor 64 antitumor effect 64 Antigen Specific 64 alefacept 64 antisense inhibitors 64 evaluating picoplatin 64 volociximab 64 Eculizumab 64 RELOVAIR ™ 64 Piperacillin 64 cyclin dependent kinase CDK 64 diagnostic radiopharmaceutical 64 receptor inhibitor 64 LSE ASM 64 receiving chemoradiation therapy 64 tetracycline antibiotic 64 R abatacept 64 Launches Generic Version 64 Factor Receptor 64 advanced hepatocellular carcinoma 64 cyclophosphamide chemotherapy 64 Demonstrates Significant 64 Squalamine 64 sitaxsentan 64 Initiate Clinical Trial 64 oral antiplatelet agent 64 Testosterone MDTS R 64 registrational Phase 64 APEX PD 64 colorectal carcinoma 64 CEQ# 64 Squamous 64 ® lenalidomide 64 dihydrochloride 64 RECORD1 64 SIX RO ROG 64 docetaxel Taxotere 64 rasagiline tablets 64 orally dosed 64 histamine dihydrochloride 64 selective antagonist 64 TASKi3 64 ® bortezomib 64 FDA Accepts 64 Deferiprone 64 Peginterferon 64 echinocandin 64 Recombinant interferon alpha 64 leukemia multiple myeloma 64 IV Busulfex 64 seliciclib CYC# 64 Perifosine KRX 64 trastuzumab Herceptin R 64 structure infections ABSSSI 64 Gleevec resistant 64 ENMD # 64 pretreatment serum 64 Phase 1a clinical 64 pertuzumab 64 Chronic Lymphocytic Leukemia CLL 64 apoptosis inducer 64 Belatacept 64 Onglyza saxagliptin 64 Soriatane R 64 Second Pivotal Phase 64 chemotherapy FOLFOX 64 polymerase inhibitor 64 Voreloxin 64 Interferon alfa 64 fostamatinib 64 HER1 64 IMC #B 64 Prodarsan R 63 alpha antagonist 63 achieved CCyR 63 lymphoid malignancies 63 HCV RESPOND 2 63 Pooled Analysis 63 Study Evaluating 63 kappa B 63 gemcitabine Gemzar 63 #mg/#mg 63 TRAIL R2 63 Ostabolin C TM 63 Zidovudine Tablets 63 telomerase therapeutic 63 Abstract Number 63 Files IND 63 trastuzumab emtansine T DM1 63 tenofovir disoproxil fumarate Viread 63 Vicriviroc 63 Drug Shows Promise 63 Lisofylline LSF 63 Varespladib 63 Vaxfectin formulated 63 surgically resected 63 signal transduction inhibitor 63 MVA HPV IL2 63 TLR7 agonist 63 HCV replicon 63 paclitaxel Taxol ® 63 personalized dendritic 63 investigational immunotherapy 63 Tezampanel 63 Tipranavir 63 ,#,# [002] 63 Aplidin R 63 1mg 2mg 63 ocular formulation 63 multicenter Phase 63 virus HCV 63 HBeAg + 63 lymphomas leukemias 63 Prospective Randomized 63 inhalation aerosol 63 Annamycin 63 cis retinoic acid 63 XYOTAX TM 63 agonist compounds 63 Intravenous immunoglobulin 63 dependent kinase inhibitor 63 mTOR inhibitor 63 compound perifosine 63 investigational hepatitis C 63 CCR5 receptor antagonist 63 administered intramuscularly 63 Anti VEGF 63 NASH Huntington 63 chronic eosinophilic leukemia 63 B Cell Lymphoma 63 NYSE Amex YMI 63 taxane resistant 63 PAOD 63 neratinib 63 CTAP# 63 mitoxantrone plus 63 irreversible inhibitor 63 commercialize deforolimus 63 ug dose 63 hip osteonecrosis avascular 63 Arimidex anastrozole 63 See CLINICAL PHARMACOLOGY 63 toenail onychomycosis 63 5 FU leucovorin 63 Diabetic Macular Edema DME 63 topical gel containing 63 #I TM# 63 non splenectomized 63 proprietary polysaccharide 63 Antiviral Therapy 63 BARACLUDE ® 63 HyperAcute 63 pediatric acute lymphoblastic 63 paclitaxel cisplatin 63 Premarket Approval Application 63 generation antisense inhibitor 63 Pazopanib 63 Panzem ® 63 Fulvestrant 63 brand ciclesonide HFA 63 Xcytrin R 63 intraepithelial neoplasia 63 Xyfid TM 63 deforolimus 63 mda 7 63 novel peptide 63 Shows Statistically Significant 63 Glypromate 63 ATRA IV 63 invasive lobular 63 Zavesca R 63 Receives Approvable Letter 63 epothilones 63 dornase alfa 63 GRN# 63 Tramiprosate ALZHEMED TM 63 Emtriva emtricitabine 63 potent topoisomerase II 63 PEG SN# 63 successfully commercialize Iluvien 63 Aclidinium 63 LAB CGRP 63 Lanthanum Carbonate 63 Ostarine ™ 63 sapacitabine CYC# 63 Afatinib 63 Randomized Double blind 63 relapsing remitting MS RRMS 63 Amrubicin 63 posaconazole 63 recurrent epithelial ovarian 63 MKC# 63 basiliximab 63 Environ Health Perspect 63 Paraplatin ® 63 Microalbuminuria 63 ALK inhibitor 63 dihydrofolate reductase 63 Acute myeloid leukemia 63 OvaRex ® MAb 63 azathioprine monotherapy 63 radiotherapeutic 63 buccal spray 63 initiated Phase 1b 63 Curaxin CBLC# 63 metastatic pancreatic 63 BRAF mutated 63 Empatic ™ 63 multicenter randomized controlled 63 ancrod 63 AEG# 63 antibody MT# 63 Early Relapsing Multiple 63 Clevudine 63 Antisoma AS# 63 pancreas esophagus 63 interferon gamma 1b 63 Levoleucovorin 63 Pafuramidine 63 Tigecycline 63 PEGylated Fab fragment 63 Commonly prescribed 63 trastuzumab Herceptin ® 63 Temodar temozolomide 63 Zybrestat 63 hypoxia activated prodrug 63 REMINYL ® 63 Multiple Myeloma MM 63 BEZ# 63 alfa 2a 63 Femring ® 63 TTR amyloidosis 63 Am J Clin 63 nonsmall cell lung cancer 63 endometrial breast 63 DGAT 63 oral JAK#/JAK# inhibitor 63 dimeglumine 63 XL# SAR# 63 Phase Ib study 63 pancreatic islet cell 63 tolevamer 63 Pruvel TM 63 estramustine 63 Dapagliflozin